Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

ADVANCED WOUND CARE
WITH NEXODYN® AOS

Wound Cleansers: a Growing Category in a Growing Market

Advanced wound care is a fast growing market mainly composed of 4 main categories: dressings, wound cleansers, negative pressure wound therapy devices and biologics.

The global market value was $9,4 bn in 2015 and it is expected to reach $13,1 bn in 2022, with a compound annual growth rate (CAGR) of 4,7 %1.

Among the leading categories of advanced wound care, wound cleansers are expected to attain $2,1bn in 2023, growing at a CAGR of 5,4%1 from 2016 to 2023. The main drivers of this growth are the aging population and the increased prevalence of chronic diseases, such as diabetes.

Non-Healing Wounds: a Challenge for Patients and Society

It is estimated that 1 % to 2 % of the population will experience a chronic wound during their lifetime in developed countries2 and this rate is increasing year after year. Stalled wounds may persist for months, even years3,4 before healing.
Due to this situation, non-healing wounds represent an economic burden for health services and patients. In 2015 only, chronic wounds represented a global expenditure of $143 bn.

https://www.apr.ch/apr-pharma-products/therapeutic-pharma/wound-management/